A‑Bec 300 mg contains abacavir, an approved nucleoside reverse transcriptase inhibitor (NRTI) used primarily in combination therapy for managing HIV infection and chronic hepatitis B. It works by blocking viral reverse transcriptase, halting viral replication and helping restore immune function. It is intended strictly for adults and taken under medical supervision alongside other antiretroviral agents.
Select options
This product has multiple variants. The options may be chosen on the product page
Entavir 0.5 mg delivers entecavir, a nucleoside analog antiviral used in the treatment of chronic hepatitis B infection. Prescribed once daily on an empty stomach, it inhibits HBV DNA replication to lower viral load and stabilize liver function. Designed for both adults and pediatric patients (age and weight criteria applicable), it is used under medical supervision for long-term disease control.
Select options
This product has multiple variants. The options may be chosen on the product page
Entavir 1 mg contains entecavir, a nucleoside analog antiviral prescribed for chronic hepatitis B management. It works by inhibiting HBV DNA polymerase, preventing viral replication and reducing liver inflammation. Taken once daily, it helps lower viral load, delay disease progression, and maintain liver function in adults and pediatric patients weighing ≥ 16 kg under medical guidance.
Select options
This product has multiple variants. The options may be chosen on the product page
HepBest 25 mg provides tenofovir alafenamide, a nucleotide analog antiviral designed for chronic hepatitis B management. Taken once daily with food or water, it suppresses HBV DNA replication, helps preserve liver function, and supports long-term treatment adherence. The formulation is optimized for enhanced kidney and bone safety compared to other tenofovir forms.
Select options
This product has multiple variants. The options may be chosen on the product page
Instgra 50 mg is an oral tablet containing dolutegravir, a potent integrase strand transfer inhibitor for treating HIV‑1 infection. Used in combination antiretroviral therapy, it blocks the HIV integrase enzyme to prevent viral replication and help restore immune function. This once‑daily formulation supports long‑term adherence in adults and adolescents weighing 30 kg and above.
Select options
This product has multiple variants. The options may be chosen on the product page
Isentress 400 mg contains raltegravir, a potent HIV integrase inhibitor that blocks viral DNA integration into host cells. Used with additional antiretrovirals, it reduces HIV‑1 viral load effectively and raises CD4 counts. This twice-daily oral tablet supports sustained viral suppression, immune system recovery, and long-term treatment adherence among adult and adolescent patients.
Select options
This product has multiple variants. The options may be chosen on the product page
Lamivir 100 mg contains lamivudine, a nucleoside reverse transcriptase inhibitor used in treating chronic hepatitis B and HIV‑1 infections. Taken once daily, it inhibits viral replication to reduce viral load and improve immune function. Often used in combination with other antivirals, Lamivir supports sustained suppression and enhances regimen adherence under medical guidance.
Select options
This product has multiple variants. The options may be chosen on the product page
Lamivir 150 mg contains lamivudine, a nucleoside reverse transcriptase inhibitor used in managing chronic hepatitis B and HIV‑1 infections. Administered once daily, this tablet inhibits viral replication to reduce viral load and improve immune function. Frequently used in combination therapy, Lamivir supports long-term treatment adherence and disease control under medical supervision.
Select options
This product has multiple variants. The options may be chosen on the product page
MyHep‑All delivers a potent combination of sofosbuvir (400 mg) and velpatasvir (100 mg), formulated as a single fixed-dose tablet for once-daily oral treatment of all genotypes of chronic hepatitis C virus (HCV) infection. This highly effective pan-genotypic regimen achieves high sustained virologic response (SVR) rates, reducing viral load, restoring liver function, and simplifying long-term adherence under medical supervision.
Select options
This product has multiple variants. The options may be chosen on the product page
✅ Key Benefits Enhances effectiveness of co-administered protease inhibitors Reduces pill burden by enabling once-daily dosing of boosted PIs Minimizes protease inhibitor metabolism for sustained viral suppression Widely used as a backbone agent in antiretroviral therapy Oral tablet offers flexible dosing for tailored treatment plans 🎯 How to Use Typically taken as one 100 mg tablet…
Select options
This product has multiple variants. The options may be chosen on the product page
Tafero-EM 200 mg/25 mg combines two antiretroviral agents—tenofovir alafenamide (25 mg) and emtricitabine (200 mg)—to support the treatment and prevention of HIV-1 infection. It is commonly used as part of pre-exposure prophylaxis (PrEP) and ongoing HIV therapy. With just one tablet daily, users benefit from effective viral suppression and reduced risk of transmission. Its tolerability and strong resistance profile make it ideal for long-term use.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
Join our newsletter and get 20% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.